triglyceride glucose index
OtherThe TyG index was calculated using the following equation: Ln [TG (mg/dL)×FPG (mg/dL) / 2].
CAD was referred to as at least one major coronary artery with≥50% stenosis evaluated by CAG
NCT Number: NCT06452121
Triglyceride glucose (TyG) index is a novel marker, which has been demonstrated to have a high sensitivity and specificity in identifying metabolic syndrome . Previous studies have shown that TyG index is associated with carotid atherosclerosis, coronary artery calcification and high risk of CVD.
This study aims to predict severity of CAD using TyG index and its correlation to coronary angiography findings.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Coronary artery disease (CAD) is characterized by vulnerable atherosclerotic plaque, which causes coronary stenosis and myocardial ischemia. The blockage of the blood vessel caused by the detachment of the endovascular plate leads to an acute CAD attack. Without timely intervention, this can be life-threatening for the patient. Currently, coronary angiography (CAG) is the reference standard for diagnosing CAD with inconclusive evidence to confirm the morbid state. Although it assesses the severity of coronary vascular occlusion, this technique is invasive and carries inherent risks.
Hypertriglyceridemia (HTG) is a common dyslipidemia and the association of triglyceride (TG) with CVD risk remains controversial . However, judging from a credible body of evidence, we can conclude that HTG is an independent risk factor of developing glucose metabolism disorders. Plasma TG levels are strongly associated with raised glucose levels because of the interactions between fat, muscle and function of pancreatic β-cells .
Moreover, accumulation of TG in the liver may cause fatty liver disease, which can increase the risk of type 2 diabetes mellitus (T2DM) . Prospective studies have revealed that plasma TG is an independent risk factor for developing T2DM . Additionally, it has been demonstrated that lowering TG, such as fibrates do, can significantly attenuate the process of developing insulin resistance . Furthermore, it also has been reported that both fasting glucose and TG within the high normal range may predict CVD risk . Hence, evaluating the joint value of TG and fasting glucose in patients with stable coronary artery disease (CAD) may be clinically in need.
Triglyceride glucose (TyG) index is a novel marker, which has been demonstrated to have a high sensitivity and specificity in identifying metabolic syndrome . Previous studies have shown that TyG index is associated with carotid atherosclerosis, coronary artery calcification and high risk of CVD.
Several studies demonstrated that the TyG index has a positive relevance with type 2 diabetes, Insulin resistence ,subclinical myocardial injury,and acute coronary syndrome (ACS). A higher TyG index correlates with a greater incidence of major adverse cardiovascular events in patients with diabetes and ACS, indicating its potential as an independent predictor for cardiovascular disease prognosis.
A recent large-scale prospective study suggested that the TyG index is an independent predictor for the progression of coronary artery calcification, especially in individuals without heavy coronary artery calcification at baseline . Moreover, an increased TyG index has been shown to be independently associated with higher risks of atherosclerotic cardiovascular diseases, including myocardial infarction, and worse prognosis in patients with ACS, irrespective of diabetes mellitus .
This study aims to predict severity of CAD using TyG index and its correlation to coronary angiography findings.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The TyG index was calculated using the following equation: Ln [TG (mg/dL)×FPG (mg/dL) / 2].
CAD was referred to as at least one major coronary artery with≥50% stenosis evaluated by CAG
Time frame: cases during 1 year of the study
Predict severity of coronary artery disease using Triglyceride glucose (TyG) index and its correlation to coronary angiography findings
Contact information is provided by the study sponsor or research team.
Assiut University
Other
Triglyceride-glucose Index as a Marker to Predict Severity of Coronary Artery Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740330
Arterial Occlusive Diseases, Arteriosclerosis
Bouge, Namur, Belgium
View Trial DetailsNCT07740044
Arrhythmias, Cardiac, Arterial Occlusive Diseases
Taizhou, Jiangsu, China
View Trial DetailsNCT07730528
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT07727135
Acute Coronary Syndrome, Angina Pectoris
Aalborg, Denmark
View Trial Details